Mechanistically, Sec62 reinforces the metastatic potentials of CRC cell via triggering the MAPK/JNK signalling pathway, which enhances the expression of UCA1 by upregulating phospho‐ATF2 (p‐ATF2) level. The gene discussed is ATF2; the disease is colorectal carcinoma.